Can calcitonin gene‐related peptide monoclonal antibodies ameliorate writer's cramp and migraine?

• Main Authors: Keisuke Suzuki (Author), Shiho Suzuki (Author), Hiroaki Fujita (Author), Hirotaka Sakuramoto (Author), Mukuto Shioda (Author), Koichi Hirata (Author)
• Format: Book
• Published: Wiley, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Recently, calcitonin gene‐related peptide (CGRP) monoclonal antibodies (mAbs) have become available as a prophylactic treatment for migraine and have shown high efficacy and safety in clinical practice. CGRP mAbs have been reported to be effective not only for migraine but also for other co...